With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

Earlier this month, Health Secretary Robert F. Kennedy Jr. announced he’s cutting nearly $500 million in funding for mRNA vaccine development from the Biomedical Advanced Research and Development ...

The mRNA vaccine drug development market presents growth opportunities through increased investment, diverse therapeutic applications, and scalable production demand. Key prospects include strategic ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

While mRNA-based COVID-19 vaccines are the best known application of the molecule, researchers around the world have found additional uses for mRNA technology beyond the realm of vaccines. They're ...

Moderna, Inc. (MRNA) is a biotechnology firm based in Cambridge, Massachusetts, that focuses on mRNA technology to create ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ transplant, a group that is at an increased risk for severe infection, ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving ...